SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cormac_Wright who wrote (307)12/21/2004 2:40:40 PM
From: idahoranch1  Read Replies (2) of 371
 
Cormac, I still communicate from time to time with management, but they are, and have been for some time, very careful about anything they say. I really don't get anything that hints at anything specific about what is ahead. They seem pleased with progress on several fronts, but that and a buck will get us a bottle of water (which is free at home). They seem to be hanging their hats on CD22 and lupus/autoimmune for the short term, which is critical for the long term. I would say they feel confident that it is the right strategy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News